V. Screpanti

发表

Overexpression of Bcl‐2 in T Cells Affects Insulitis in the Nonobese Diabetic Mouse

N. Brenden, C. Rietz, V. Screpanti, 2003, Scandinavian journal of immunology.

Neonatal Pattern of VH Gene Utilization in Nonobese Diabetic Mice Does not Correlate with Development of Insulitis

N. Brenden, C. Rietz, V. Screpanti, 2001, Scandinavian journal of immunology.

Cell Vaccination Efficacy Dendritic Cells In Vivo and Limits Dendritic NK Cell TRAIL Eliminates Immature

H. Ljunggren, M. Smyth, H. Yagita, 2003 .

Regulation of perforin‐independent NK cell‐mediated cytotoxicity

H. Ljunggren, A. Grandien, J. Michaëlsson, 2003, European journal of immunology.

CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

A. Grandien, H. Yagita, B. Bogen, 2004, Cancer Immunology, Immunotherapy.

A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells1

H. Ljunggren, A. Grandien, R. Wallin, 2001, The Journal of Immunology.

NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy 1

H. Ljunggren, M. Smyth, A. Grandien, 2004, The Journal of Immunology.

The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

P. Biberfeld, M. Djerbi, A. Grandien, 1999, The Journal of experimental medicine.

Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.

Hans-Gustaf Ljunggren, H. Ljunggren, A. Grandien, 2005, Molecular immunology.

Leukemia inhibitor factor (LIF) inhibits HIV-1 replication via restriction of stat 3 activation.

J. Andersson, A. Grandien, P. Nowak, 2007, AIDS research and human retroviruses.